LCN2 and stroke disorder: Bone MSC- (BMSC-) derived exosomes with miR-138-5p target the lipocalin 2 (LCN2) on astrocytes and reduce the neurological impairment by inhibiting the astrocytes' inflammatory response and apoptosis after stroke [65].